Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Wabtec
WAB
$49.3B
| $25.5M | 0.02% |
+328,195
| New | +$24.3M |
|
|
ACHN
877
DELISTED
Achillion Pharmaceuticals
ACHN
| $25.5M | 0.02% |
4,231,600
+379,000
| +10% | +$2.19M |
|
878
Welltower
WELL
$174B
| $25.4M | 0.02% |
310,760
-278,201
| -47% | -$23.8M |
|
879
Buckle
BKE
$2.32B
| $25.3M | 0.02% |
936,450
+158,600
| +20% | +$3.77M |
|
880
First American
FAF
$7.98B
| $25.3M | 0.02% |
433,400
+244,900
| +130% | +$15M |
|
881
Utah Medical Products
UTMD
$226M
| $25.3M | 0.02% |
234,214
-3,300
| -1% | -$334K |
|
882
PTC
PTC
$15.3B
| $25.2M | 0.02% |
+336,700
| New | +$24M |
|
|
CVA
883
DELISTED
Covanta Holding Corporation
CVA
| $25.1M | 0.02% |
1,693,361
+238,961
| +16% | +$3.64M |
|
|
GLDD
884
DELISTED
Great Lakes Dredge & Dock
GLDD
| $25M | 0.02% |
2,209,101
+183,800
| +9% | +$1.96M |
|
885
Quanex
NX
$825M
| $24.9M | 0.02% |
1,460,207
+407,407
| +39% | +$7.67M |
|
886
Pediatrix Medical
MD
$2.2B
| $24.9M | 0.02% |
896,670
+171,370
| +24% | +$4.3M |
|
887
Vishay Intertechnology
VSH
$4.6B
| $24.9M | 0.02% |
1,170,013
-684,000
| -37% | -$13.3M |
|
|
PFC
888
DELISTED
Premier Financial Corp. Common Stock
PFC
| $24.9M | 0.02% |
789,700
-49,700
| -6% | -$1.5M |
|
889
Carnival Corporation Ltd
CCL
$38.1B
| $24.9M | 0.02% |
489,100
-964,100
| -66% | -$43.1M |
|
890
News Corp Class B
NWS
$17.7B
| $24.8M | 0.02% |
1,710,053
+314,153
| +23% | +$4.33M |
|
891
Global Net Lease
GNL
$1.87B
| $24.8M | 0.02% |
1,222,595
-223,003
| -15% | -$4.4M |
|
|
PLAN
892
DELISTED
Anaplan, Inc.
PLAN
| $24.8M | 0.02% |
473,100
+417,514
| +751% | +$20.7M |
|
893
Cheniere Energy
LNG
$54.2B
| $24.8M | 0.02% |
405,888
-892,660
| -69% | -$54.9M |
|
894
Exelon
EXC
$48.1B
| $24.7M | 0.02% |
761,006
-975,825
| -56% | -$31.6M |
|
|
AMAG
895
DELISTED
AMAG Pharmaceuticals
AMAG
| $24.7M | 0.02% |
2,030,200
-4,000
| -0.2% | -$43.7K |
|
896
Silicon Laboratories
SLAB
$7.14B
| $24.7M | 0.02% |
212,898
+159,200
| +296% | +$17.5M |
|
897
Park Aerospace
PKE
$720M
| $24.7M | 0.02% |
1,517,397
-7,300
| -0.5% | -$121K |
|
898
Hudbay
HBM
$9.76B
| $24.7M | 0.02% |
5,945,809
+790,000
| +15% | +$2.86M |
|
|
AD
899
Array Digital Infrastructure
AD
$3.04B
| $24.6M | 0.02% |
679,662
-4,500
| -0.7% | -$158K |
|
900
TechTarget
TTGT
$327M
| $24.6M | 0.02% |
940,800
+144,800
| +18% | +$3.67M |
|
Similar funds
Renaissance Technologies's Q4 2019 Portfolio in Review
As of Q4 2019, Renaissance Technologies held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Renaissance Technologies's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Renaissance Technologies's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Renaissance Technologies fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Renaissance Technologies's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Renaissance Technologies opened 518 new positions and closed 443 in Q4 2019.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.